News
November 2026
2artifacts
News
🔬 Emerging Technology Watch
Marvell agrees to buy Lumentum for $115 billion in stock, consolidating the optical interconnect supply chain that AI data centers increasingly depend on — Productionized (both firms ship today; the…
2026-11-05 emerging-tech
News
🔬 Emerging Technology Watch
Inovio's Voceryq wins FDA approval — a DNA-based immunotherapy for recurrent respiratory papillomatosis, priced at $460,000 and now the second approved drug for the disease — Productionized.
2026-11-04 emerging-tech